Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study-Reference-Cited by-同舟云学术

Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

Published:2020-04 Issue:4 Volume:21 Page:551-560
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Karol Seth E,Alexander Thomas B,Budhraja Amit,Pounds Stanley B,Canavera Kristin,Wang Lei,Wolf Joshua,Klco Jeffery M,Mead Paul E,Das Gupta Soumyasri,Kim Su Y,Salem Ahmed Hamed,Palenski Tammy,Lacayo Norman J,Pui Ching-Hon,Opferman Joseph T,Rubnitz Jeffrey E

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012;Rasche;Leukemia,2018

2. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial;Rubnitz;Lancet Oncol,2010

3. Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531;Gamis;J Clin Oncol,2014

4. Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia;Pan;Cancer Discov,2014

5. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells;Konopleva;Br J Haematol,2002

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria and Acute Leukemia: A Clinician’s Perspective;International Journal of Molecular Sciences;2024-09-07

2. Venetoclax for pediatric patients with newly diagnosed acute myeloid leukemia;Pediatric Blood & Cancer;2024-08-16

3. Challenges and considerations for antifungal prophylaxis in children with acute myeloid leukemia;Expert Review of Hematology;2024-08-12

4. Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients;British Journal of Haematology;2024-07-31

5. Single-cell analysis of pediatric acute myeloid leukemia samples uncovers treatment-resistant stem and mast cells;2024-07-10